Cargando…
Bayesian networks established functional differences between breast cancer subtypes
Breast cancer is a heterogeneous disease. In clinical practice, tumors are classified as hormonal receptor positive, Her2 positive and triple negative tumors. In previous works, our group defined a new hormonal receptor positive subgroup, the TN-like subtype, which had a prognosis and a molecular pr...
Autores principales: | Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Arevalillo, Jorge M., López-Vacas, Rocío, López-Camacho, Elena, Prado-Vázquez, Guillermo, Zapater-Moros, Andrea, Díaz-Almirón, Mariana, Ferrer-Gómez, María, Navarro, Hilario, Nanni, Paolo, Zamora, Pilar, Espinosa, Enrique, Maín, Paloma, Fresno Vara, Juan Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289386/ https://www.ncbi.nlm.nih.gov/pubmed/32525929 http://dx.doi.org/10.1371/journal.pone.0234752 |
Ejemplares similares
-
Computational models applied to metabolomics data hints at the relevance of glutamine metabolism in breast cancer
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2020) -
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
por: Prado-Vázquez, Guillermo, et al.
Publicado: (2019) -
Probabilistic graphical models relate immune status with response to neoadjuvant chemotherapy in breast cancer
por: Zapater-Moros, Andrea, et al.
Publicado: (2018) -
Biological molecular layer classification of muscle-invasive bladder cancer opens new treatment opportunities
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2019) -
Molecular characterization of breast cancer cell response to metabolic drugs
por: Trilla-Fuertes, Lucía, et al.
Publicado: (2018)